Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2

Nicholas Bodor, Yasuo Oshiro, Thorsteinn Loftsson, Michael Katovich, Robert William Caldwell

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The “inactive metabolite approach” was used to design β-blockers. The acidic inactive metabolite of metoprolol [4-(2-hydroxy-3-isopropylamino) propoxyphenylacetic acid] was used as the lead compound. Its esters (alkyl and cycloalkyl) were found active in vivo while reverting quantitatively to the same inactive metabolite in plasma. The cyclohexyl ester showed the best activity, which was cardioselective, similar to the parent compound metoprolol. Although most esters had a plasma half-life of approximately 1 min, their activity (antagonism of isoproterenol induced increase in heart rate) following intravenous administration lasted 45–90 minutes, and the maximum β-blockade was observed at 45–60 minutes in both rats and dogs.

Original languageEnglish (US)
Pages (from-to)120-125
Number of pages6
JournalPharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists
Volume1
Issue number3
DOIs
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Metabolites
Esters
Metoprolol
Pharmaceutical Preparations
Lead compounds
Plasmas
Isoproterenol
Intravenous Administration
Half-Life
Rats
Heart Rate
Dogs
Acids

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2. / Bodor, Nicholas; Oshiro, Yasuo; Loftsson, Thorsteinn; Katovich, Michael; Caldwell, Robert William.

In: Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, Vol. 1, No. 3, 01.01.1984, p. 120-125.

Research output: Contribution to journalArticle

@article{7ec142b2c7d34934beff66c518fc0bdb,
title = "Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2",
abstract = "The “inactive metabolite approach” was used to design β-blockers. The acidic inactive metabolite of metoprolol [4-(2-hydroxy-3-isopropylamino) propoxyphenylacetic acid] was used as the lead compound. Its esters (alkyl and cycloalkyl) were found active in vivo while reverting quantitatively to the same inactive metabolite in plasma. The cyclohexyl ester showed the best activity, which was cardioselective, similar to the parent compound metoprolol. Although most esters had a plasma half-life of approximately 1 min, their activity (antagonism of isoproterenol induced increase in heart rate) following intravenous administration lasted 45–90 minutes, and the maximum β-blockade was observed at 45–60 minutes in both rats and dogs.",
author = "Nicholas Bodor and Yasuo Oshiro and Thorsteinn Loftsson and Michael Katovich and Caldwell, {Robert William}",
year = "1984",
month = "1",
day = "1",
doi = "10.1023/A:1016376003515",
language = "English (US)",
volume = "1",
pages = "120--125",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2

AU - Bodor, Nicholas

AU - Oshiro, Yasuo

AU - Loftsson, Thorsteinn

AU - Katovich, Michael

AU - Caldwell, Robert William

PY - 1984/1/1

Y1 - 1984/1/1

N2 - The “inactive metabolite approach” was used to design β-blockers. The acidic inactive metabolite of metoprolol [4-(2-hydroxy-3-isopropylamino) propoxyphenylacetic acid] was used as the lead compound. Its esters (alkyl and cycloalkyl) were found active in vivo while reverting quantitatively to the same inactive metabolite in plasma. The cyclohexyl ester showed the best activity, which was cardioselective, similar to the parent compound metoprolol. Although most esters had a plasma half-life of approximately 1 min, their activity (antagonism of isoproterenol induced increase in heart rate) following intravenous administration lasted 45–90 minutes, and the maximum β-blockade was observed at 45–60 minutes in both rats and dogs.

AB - The “inactive metabolite approach” was used to design β-blockers. The acidic inactive metabolite of metoprolol [4-(2-hydroxy-3-isopropylamino) propoxyphenylacetic acid] was used as the lead compound. Its esters (alkyl and cycloalkyl) were found active in vivo while reverting quantitatively to the same inactive metabolite in plasma. The cyclohexyl ester showed the best activity, which was cardioselective, similar to the parent compound metoprolol. Although most esters had a plasma half-life of approximately 1 min, their activity (antagonism of isoproterenol induced increase in heart rate) following intravenous administration lasted 45–90 minutes, and the maximum β-blockade was observed at 45–60 minutes in both rats and dogs.

UR - http://www.scopus.com/inward/record.url?scp=0021258295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021258295&partnerID=8YFLogxK

U2 - 10.1023/A:1016376003515

DO - 10.1023/A:1016376003515

M3 - Article

AN - SCOPUS:0021258295

VL - 1

SP - 120

EP - 125

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 3

ER -